Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



3 Biggest Biotech Crashes in April

Biotech stocks can skyrocket into the stratosphere on good news. Unfortunately, they can also crash (and sometimes burn) when bad news comes their way.

In this video, The Motley Fool's Erin Miller talks with Fool contributor Keith Speights about three of the biggest biotech crashes during the month of April. Dyax (UNKNOWN: DYAX.DL  ) won the dubious honor as the biggest crash of the month after abysmal results for angioedema drug Kalbitor.

Rigel Pharmaceuticals (NASDAQ: RIGL  ) also had a horrible April, with disappointing news from partner AstraZeneca's (NYSE: AZN  ) clinical study of rheumatoid arthritis drug Fostamatanib. And previously high-flying Sarepta Therapeutics (NASDAQ: SRPT  ) felt the effects of gravity, as concerns arose about accelerated approval for Duchenne muscular dystrophy drug eteplirsen. (NYSE: ABBV  )

Watch as Erin and Keith discuss these big biotech crashes -- and which of the three looks most likely to emerge from the rubble.

While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report, "3 Stocks That Will Help You Retire Rich," names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2402367, ~/Articles/ArticleHandler.aspx, 9/29/2016 8:27:58 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,143.45 -195.79 -1.07%
S&P 500 2,151.13 -20.24 -0.93%
NASD 5,269.15 -49.39 -0.93%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
DYAX.DL $0.00 Down +0.00 +0.00%
Dyax CAPS Rating: **
RIGL $3.57 Down -0.13 -3.51%
Rigel Pharmaceutic… CAPS Rating: ***
SRPT $60.98 Down -1.26 -2.02%
Sarepta Therapeuti… CAPS Rating: **
AZN $33.05 Down -0.77 -2.28%
AstraZeneca CAPS Rating: ****